<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01554774</url>
  </required_header>
  <id_info>
    <org_study_id>HVVV-CBM-01</org_study_id>
    <nct_id>NCT01554774</nct_id>
  </id_info>
  <brief_title>Non-invasive Assessment of Pulmonary Vascular Resistance in Elderly Patients With Chronic Obstructive Pulmonary Disease</brief_title>
  <acronym>PVR-COPD</acronym>
  <official_title>Observational Study of Comparison of Echocardiographic Markers of Right Ventricular Function and Electrocardiographic Signs of Chronic Cor Pulmonale in Elderly Patient With COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Viamed Valvanera, Spain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Campus Bio-Medico University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Viamed Valvanera, Spain</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many studies have evaluated the viability of measuring the pulmonary vascular resistance
      (PVR) by non-invasive methods in patients with pulmonary hypertension, pulmonary
      thromboembolism, ischemic cardiopathy and valvular disease. The investigators have not found
      other studies which evaluate the PVR in elderly patients with COPD. The hypothesis is that in
      patients with COPD, the severity of obstruction, expressed by GOLD class, is associated with
      an increase of PVR.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>right ventricular function and GOLD stages</measure>
    <time_frame>cross sectional</time_frame>
    <description>To compare right ventricular function, evaluated by a non-invasive method such as echocardiography, with the GOLD stages in chronic obstructive pulmonary disease (COPD) patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Right ventricular function and FEV1.</measure>
    <time_frame>cross sectional</time_frame>
    <description>Compare right ventricular function, evaluated by a non-invasive method such as echocardiography, tricuspid annulus plane systolic excursion (TAPSE),pulmonary artery systolic pressure (PAPs) and fractional area change (FAC), with the GOLD stages in chronic obstructive pulmonary disease (COPD) patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ECG and echocardiography parameters of cor pulmonale</measure>
    <time_frame>cross sectional</time_frame>
    <description>The correlation between right ventricular function and the electrocardiographic parameters of cor pulmonale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricle function and 6M-WT.</measure>
    <time_frame>cross sectional</time_frame>
    <description>Evaluate the correlation between the hemodynamic indices of right ventricle and the six minute walking test (6M-WT).</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Pulmonary Hypertension</condition>
  <condition>Cor Pulmonale</condition>
  <arm_group>
    <arm_group_label>GOLD II</arm_group_label>
    <description>Will be included in this group the patients with COPD stage II</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GOLD III</arm_group_label>
    <description>Will be included in this group the patients with COPD stage III</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GOLD IV</arm_group_label>
    <description>Will be included in this group the patients with COPD stage VI.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive series of patients with a diagnosis of COPD who were treated in the consulting
        rooms of the department of respiratory physiopathology.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of COPD stage II, III or IV according to the GOLD guidelines

          -  signed the informed consent

        Exclusion Criteria:

          -  ischemic cardiopathy

          -  severe valvular disease

          -  atrial fibrillation

          -  left bundle branch block
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincenzo Malafarina, MD MSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Viamed Valvanera, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raffaele Antonelli Incalzi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Campus Bio-Medico University. S. Raffaele - Cittadella della Carità Foundation, Taranto, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Campus Bio-Medico University</name>
      <address>
        <city>Roma</city>
        <zip>00128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Incalzi RA, Fuso L, De Rosa M, Di Napoli A, Basso S, Pagliari G, Pistelli R. Electrocardiographic signs of chronic cor pulmonale: A negative prognostic finding in chronic obstructive pulmonary disease. Circulation. 1999 Mar 30;99(12):1600-5.</citation>
    <PMID>10096937</PMID>
  </reference>
  <reference>
    <citation>Scapellato F, Temporelli PL, Eleuteri E, Corrà U, Imparato A, Giannuzzi P. Accurate noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with chronic failure heart failure. J Am Coll Cardiol. 2001 Jun 1;37(7):1813-9.</citation>
    <PMID>11401116</PMID>
  </reference>
  <reference>
    <citation>Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ. A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol. 2003 Mar 19;41(6):1021-7.</citation>
    <PMID>12651052</PMID>
  </reference>
  <reference>
    <citation>Bossone E, Bodini BD, Mazza A, Allegra L. Pulmonary arterial hypertension: the key role of echocardiography. Chest. 2005 May;127(5):1836-43. Review.</citation>
    <PMID>15888866</PMID>
  </reference>
  <reference>
    <citation>Milan A, Magnino C, Veglio F. Echocardiographic indexes for the non-invasive evaluation of pulmonary hemodynamics. J Am Soc Echocardiogr. 2010 Mar;23(3):225-39; quiz 332-4. doi: 10.1016/j.echo.2010.01.003. Review.</citation>
    <PMID>20206827</PMID>
  </reference>
  <reference>
    <citation>Haddad F, Zamanian R, Beraud AS, Schnittger I, Feinstein J, Peterson T, Yang P, Doyle R, Rosenthal D. A novel non-invasive method of estimating pulmonary vascular resistance in patients with pulmonary arterial hypertension. J Am Soc Echocardiogr. 2009 May;22(5):523-9. doi: 10.1016/j.echo.2009.01.021. Erratum in: J Am Soc Echocardiogr. 2010 Apr;23(4):376.</citation>
    <PMID>19307098</PMID>
  </reference>
  <reference>
    <citation>Kim SH, Yi MZ, Kim DH, Song JM, Kang DH, Lee SD, Song JK. Prognostic value of echocardiographic estimation of pulmonary vascular resistance in patients with acute pulmonary thromboembolism. J Am Soc Echocardiogr. 2011 Jun;24(6):693-8. doi: 10.1016/j.echo.2011.02.002. Epub 2011 Mar 24.</citation>
    <PMID>21439783</PMID>
  </reference>
  <reference>
    <citation>Farzaneh-Far R, Na B, Whooley MA, Schiller NB. Usefulness of noninvasive estimate of pulmonary vascular resistance to predict mortality, heart failure, and adverse cardiovascular events in Patients With stable coronary artery disease (from the Heart and Soul Study). Am J Cardiol. 2008 Mar 15;101(6):762-6. doi: 10.1016/j.amjcard.2007.11.010. Epub 2008 Feb 21.</citation>
    <PMID>18328836</PMID>
  </reference>
  <reference>
    <citation>Choi EY, Shim J, Kim SA, Shim CY, Yoon SJ, Kang SM, Choi D, Ha JW, Rim SJ, Jang Y, Chung N. Value of echo-Doppler derived pulmonary vascular resistance, net-atrioventricular compliance and tricuspid annular velocity in determining exercise capacity in patients with mitral stenosis. Circ J. 2007 Nov;71(11):1721-7.</citation>
    <PMID>17965491</PMID>
  </reference>
  <reference>
    <citation>Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med. 2003 Mar 1;167(5):735-40. Epub 2002 Dec 12.</citation>
    <PMID>12480614</PMID>
  </reference>
  <reference>
    <citation>Barberà JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J. 2003 May;21(5):892-905. Review.</citation>
    <PMID>12765440</PMID>
  </reference>
  <reference>
    <citation>Burgess MI, Ray S, Mogulkoc N, Egan J, Incalzi RA, Fuso L, Marino De Rosa, Di Napoli A, Basso S, Pagliari G, Pistelli R. Doppler echocardiographic index of global right ventricular function. Circulation. 2000 Mar 28;101(12):E117.</citation>
    <PMID>10736299</PMID>
  </reference>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2012</study_first_submitted>
  <study_first_submitted_qc>March 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2012</study_first_posted>
  <last_update_submitted>February 6, 2015</last_update_submitted>
  <last_update_submitted_qc>February 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Viamed Valvanera, Spain</investigator_affiliation>
    <investigator_full_name>Vincenzo Malafarina, MD MSc</investigator_full_name>
    <investigator_title>MD MSc</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>PVR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Pulmonary Heart Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

